Firms that significantly reduce their executive stock options have 66 percent lower R&D investment two years later.
Source: Michael Hickfang and Ulrike Holder, “The Impact of Stock Options on Risk-Taking: Founder-CEOs and Innovation,” Discussion Paper of the Institute for Organizational Economics, December 2018.
Commentary: Aligning executive incentives such as stock options with firms’ long-term growth objectives is crucial for promoting innovation. A new study examined the magnitude of this effect, focusing on a 2005 change in tax regulations that made providing stock options more expensive. The researchers compared firms that significantly reduced stock options as a share of executive compensation to firms that didn’t, and they found that after two years the firms that reduced stock options had also reduced their R&D investments by 66 percent relative to their counterparts.